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ABSTRACT 
Macromolecules have been widely useful for drug delivery purpose. The fusion of drug with macromolecule could offer controlled or time 
specific drug delivery. Glyco amino acids are a carbohydrate derivative which occurs in nature as a subunit of oligosaccharides in cell walls of 
bacteria and in some antibiotic. Glyco-peptide presents an exclusive research in glycobiology for drug discovery, drug delivery and other 
biotechnological application. This work was on the synthesis and characterization of glyco amino acids based on monosaccharide (D-
glucosamine) and amino acids as reactant. The synthesized compound was characterised by physicochemical properties and their spectral 
analysis. These glycosylated amino acid building blocks can be utilized in the synthesis of glycopeptides, generation of glycomimetic libraries, 
Preparation of glycoconjugates, glycotargetting, and inhibition of carbohydrate-protein binding. 
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INTRODUCTION 
Drug delivery talk about to technologies, approaches, 
systems and formulations for transporting 
a therapeutic compound in the body. It involves scientific 
site-targeting within the body. Drug delivery is an idea 
combined with route of administration and dosage form. 
These technologies modify drug’s ADME properties 
improving product efficacy, safety, patient convenience and 
compliance. 
The development of new formulations confirms a better 
pharmacological response, which improve the 
bioavailability, lower the doses and minimize side effects of 
drug. In the research of drug delivery systems, we try to 
advance the pharmacological activity of API on improving 
ADME of drug.  
The high molecular weight carriers are the vital constituents 
of drug delivery systems in which the drug is covalently 
bound or fixed. Hence, the carriage of drugs to the site of 
action is the main function of polymeric carrier. Polymeric 
carrier protect the drugs to interact with other molecule. 
This interaction may change the chemical structure of active 
pharmaceutical ingredient which may cause lose its 
pharmaceutical action. 
The mechanism of these polymers is an essential feature by 
which they are eliminate from the body. These polymers 
may be excreted rightly via renal excretion or may be 
excrete metabolically. Non-biodegradable macromolecules 
with a molecular weight lower than 50 KDa can be safely 
cleared from the body. The passage through the renal 
glomerular membrane depends on chemical structure of the 
molecule. The molecular weight of the substance should be 
under 50 KDa for clearance through renal glomerular 
membrane. In the case of non-biodegradable polymer, the 
drug can be covalently joined to the macromolecule by a 
linker. Some conditions are needed to degrade these 
polymers such as different enzyme or an acidic medium. 
Other things to consider in non-biodegradable polymer 
design is polymer’s chemical structure (degree of 
hydrophobicity, covalent bonding of monomers, etc.), since 
the degradation condition and speed and therefore, the rate 
and site of drug release, can be modulated depending on the 
chemical structure of the polymer used. Current efforts in 
the field of drug delivery system are the formulations in 
which the active constituent is released in a controlled 
manner over a period of time from the formulation and 
strategy to enhance survival of oral formulation. The 
designed system must avoid the host's defense mechanisms 
and reach to its intended site of action to achieve efficient 
targeted delivery. 
The main purpose of polymeric transporters is to protect 
the drug from interacting with other molecules and carriage 
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to the site of action. Chemical structure can be changed by 
the interaction. Moreover, polymeric carriers evade the 
interaction of the drug with other undesirable molecules 
such as proteins, which could seize the drug stopping its 
entrance at the site of action. To obtaining the ideal release 
conditions the polymeric structure should be 
i) biodegradable 
ii) disassembled 
iii) undissembled 
Micro-sized polymeric carriers could be used in first two 
cases. Nano-sized polymers must be used for renal 
elimination if the arrangement of the polymer is non-
biodegradable.  
Smart polymers also can be used in drug delivery system. 
The structure of these polymer may change once they are 
induced by a stimulation which causes the release of drug at 
the appropriate time and place.  
In controlled drug release, polymer does not have any 
specific therapeutic action. These polymer are used as 
excipient in the formulation. Drug are conjugated in 
polymer matrices for drug delivery purpose.The objective of 
drug polymer conjugates to improve the internalization and 
specificity of cell to achieve ideal release of the drug at the 
site of action. 
When drugs are attached to the polymer with the aid of 
linkers the conjugation of drug and polymer play a 
significant role. These conjugations should be alter by 
certain gastric enzymes or acidic environments. This 
phenomenon works on nanoparticles, which have great 
movement in the tiniest vessels, allowing for selective drug 
accumulation and efficient uptake at the site of action. 
Depending on the preferred application to overcome 
physiological barriers, Nano-delivery systems must have a 
definite particle size, surface charge and hydrophobicity. 
The physiological mechanisms of these barriers prevent 
nanoparticles from reaching their targets, thus 
compromising therapeutic efficiency [1]. 
In current times, polymeric carriers for drugs of cancer have 
been widely studied. Due to certain differences in the 
characteristics of healthy and malignant tissue polymer can 
accumulate unreceptively in malevolent tissue. In general, 
micro molecules diffuse through the endothelial cell wall to 
healthy and malignant tissues. Endothelial cells of 
malevolent tissues have more and large opening that allows 
large molecules to cross endothelial cell wall of these 
tissues. Malevolent tissue also have poor lymphatic drainage 
and increased vascularity, which both lead to the retention 
of macromolecules. This unreceptive accumulation of 
macromolecules in cancer tissue, known as the EPR effect 
(enhanced permeability and retention effect). 
Glyco-amino-acids are the sugar moieties in which sugar 
attached to an amino acid by covalent bond. Glycol-amino-
acid contains at least one amino and one carboxyl group in 
their structure. Amino acid linked with saccharide through a 
glycosyl linkage (-O, -N) to form glycosyl amino acid. 
Oligopeptide linked to carbohydrate to form glycopeptide. 
The glyco amino acids are synthesized from commercially 
obtainable or easily available mono saccharide, i.e., glucose, 
glucosamine, diacetone glucose, galactose etc. The large 
quantity of functional groups and the choice of stereo 
chemical linkages at the anomeric carbon has constantly 
challenged toward a multitude of approaches to this 
compounds. Monosaccharides are privileged structures with 
rigid molecular systems or which can be used as molecular 
templates to display pharmacophoric groups in distinct 
spatial orientations. For the generation of carbohydrate 
building blocks, at least one carboxyl and one amine 
functional group was incorporated into the sugar ring. 
Derivatives of amine containing sugars such as N- acetyl 
glucosamine and sialic acid whose nitrogen are the part of 
more complex functional groups rather than formally being 
amines are also considered amino sugars. Amino glycosides 
are class of antimicrobial compounds that inhibits protein 
synthesis in bacteria’s and these compounds are conjugates 
of amino sugar [2]. 
The viability of using carbohydrate ligands to target protein 
receptors at sites of localization, called glycotargeting, the 
potential of using carbohydrates in targeted drug delivery 
system has been made vibrant. The use of glycoconjugates 
may be divided into two types-  
(i) Glycoconjugates is itself act as drug  
(ii) Glycoconjugates plays a role in helping the delivery of 
the drug.  
Glycoproteins represent outstanding objects for the drug 
targeting; the structure can be modified with regard to the 
protein backbone as well the functional sugar group. Small 
molecule of drugs can be glycosylated which having the 
potential to pass into the kidneys, and be rapidly cleared. 
Therefore, macromolecules that allow extended circulation 
time and give entrance to added chemical functionality or 
more specific delivery is an attractive alternative.  
MATERIAL AND METHODS 
All chemicals used in the synthesis of glyco-amino acids 
were purchased from different resources and used without 
any further purification. 
Synthesis of each glyco amino acid conjugates were carried 
out in following steps. 
(A) BOC protection of amino acid: 
The procedure for the preparation of BOC protected amino 
acids was adopted as described by Shendage D.M. (2004) [3]. 
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(B) Protection of D-glucosamine: 
The procedure for the protection of D-glucosamine was adopted as described by Mauro De Nisco (2012) [4].  
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(C) De-protection of amine group of D-glucosamine: 
Mischmetal (MM) (8.6 g, 61 mmol) was added to 250 ml of 
dry Tetrahydrofuran and activated with 18 ml (93 mmol) of 
TMSCl by refluxing under a nitrogen atmosphere for 30 min. 
Then, 10 mmols of compound 5 (1,3,4,6-tetra-O-acetyl-
2(2,2,2-trichloroethoxycarbonylamino)-D-glucopyranose), 
obtained in previous step was added and refluxed until thin-
layer chromatography (TLC; EtOAc–hexane) showed the 
completion of reaction. Before TLC, the sample was 
quenched with saturated Na2CO3. Mischmetal was filtered 
after the completion of reaction and the resulting filtrate 
was treated with 300 ml of saturated aqueous solution of 
sodium carbonate, stirred for 5 min, and then extracted with 
CH2Cl2 (5x300 ml) and with ethyl acetate (3x300 ml). The 
combined organic layers were washed with 0.2 M citric acid 
aqueous solution, twice with distilled water, and then dried 
over anhydrous magnesium sulfate. The resulting mixture 
was filtered and concentrated by rotavap [4]. 
  
Scheme: 3 
O
AcO
AcO
OAc
OAcNHTroc
(v)
O
AcO
AcO
OAc
OAc
NH2
(v) TMSCl, MM, dry DMF, Reflux
(5) 1,3,4,6-tetra-O-acetyl-2(2,2,2-
trichloroethoxyamino)-D-glucopyranose
(6) 1,3,4,6-tetra-O-acetyl-D-glucosamine
 
(D) Conjugation of BOC protected amino acids with 
protected D-glucosamine: 
To a magnetically stirred solution of BOC amino acid (10 
mmoles), in anhydrous CH2Cl (50 ml) in an ice bath, HOBT 
(2.7 gm, 20 mmoles) was added in one portion. After 30 
min. a solution of compound 6 (5.0 gm, 9.3 mmoles) and 
EDC (18 ml, 10 mmoles) in the anhydrous CH2Cl (50 ml) 
was added dropwise at same temperature. The mixture was 
stirred for 12 hours in an ice bath and then allowed to warm 
slowly to room temperature. A precipitate was filtered off 
and the solution was washed with saturated NaHCO3, brine, 
until neutral, and then dried over Na2SO4. Solvent was 
evaporated under reduced pressure. 
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(
E) De-protection of glyco-amino acids: 
(i) Compound 7 (N-BOC aminoacyl 1,3,4,6 tetra acetyl D-
glucosamine), obtained from previous step was 
dissolved by a saturated solution of NH3 in dry methanol 
(40 ml), in ice bath. Stirred for 12 hrs. Evaporation of 
solvent was done under controlled reduced pressure. 
(ii) 10 mmols of compound (8) was dissolved in 5 
equivalent of THF (4 ml) and CH2Cl2 (3.2 ml) and stirred 
for 2 hours at room temperature. Evaporation of solvent 
was done under controlled reduced pressure Compound 
9(N-aminoacyl D-glucosamine) was obtained as final 
product.
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RESULTS AND DISCUSSION 
Glyco amino acids and their derivatives were synthesized by 
coupling of amino acids to the monosaccharide unit at 
optimized parameters of reaction. In this synthesis BOC 
protected amino acids were reacted with protected D- 
glucosamine to form different building blocks of glyco 
amino acids.  
The synthesis of glyco amino acids involved various 
protection and de-protection steps to prevent side 
reactions. Scheme 1 and 2 schematically illustrated the 
procedure for the protection of different amino acids and D-
glucosamine respectively. The synthesized glyco amino 
acids were characterized by physicochemical properties and 
analysis by, infrared spectroscopy, Nuclear magnetic 
resonance spectroscopy, and Mass spectroscopy.  
The FT-IR spectra of different glyco amino acids displayed 
peaks around 900 and 1150 cm-1 of assigned saccharide 
structure. The peak in the range of 3475-3150 cm-1 showed 
the N-H stretch and in the range of 1700-1600 cm-1 showed 
the C=O stretch confirmed the amide bond formation. 
Further confirmation of structure of different glyco amino 
acids were done by Mass and 1H NMR Spectroscopy 
Physicochemical parameters of synthesized Glyco-amino 
acids (GAAs): 
The results of physicochemical properties are summarized 
in tables as given below: 
 
Table 1: Physicochemical parameters of synthesized GAAs 
S. 
No. 
Compound 
code 
Amino 
acid 
R Appearance Solubility M.P.    C) Rf Value 
(4:1) 
1. GAA-1 Glycine -H Light Brown Methanol 140-145 0.79 
2. GAA-2 Isoleucine -CH(C2H5) CH3 White Water, Methanol 165-170 0.65 
3. GAA-4 Leucine -CH2CH(CH3)2 White Water, Methanol Decomposed 
on heating 
0.83 
4. GAA-5 Alanine -CH3 Pale White Water, Methanol 120-125 0.83 
5. GAA-6 valine -CH(CH3)2 Snow White Water, Methanol 150-155 0.89 
 
Spectral analysis of synthesized Glyco amino acids (GAAs): 
Table 2: Molecular mass data of synthesized GAAs 
S. No. Compound Code Exact mass Fragments mass Fragments formula Molec-ular ion peak 
1. GAA-01 236.1 132.05 C4H8N2O3 252.1 
2. GAA-02 292.16 188.16 C8H16N2O3 339.4 
3. GAA-04 292.16 188.16 C8H16N2O3 305.2 
4. GAA-05 250.12 146.06 C5H10N2O3 252.1 
5. GAA-06 278.15 174.1 C7H14N2O3 287.1 
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Table 3: IR absorption band of synthesized GAAs 
 
Compound Code 
 Bond Type 
 N-H C-H C-N O-H 
GAA-01 3280.09 cm-1 2875.99 cm-1 1065.72-1229.67 cm-1   3243.44cm-1 
GAA-02 3218.37 cm-1 2878.88 cm-1 1076.33-1270.18 cm-1 3218.37 cm-1 
GAA-04 3288.77 cm-1 2877.92 cm-1 1004.96-1247.03 cm-1 3201.97 cm-1 
GAA-05 3289.74 cm-1 2876.95 cm-1 1007.88-1247.03 cm-1 3289.74 cm-1 
GAA-06 3286.84 cm-1 2879.85 cm-1 1003.93-1259-37 cm-1 3286.84 cm-1 
 
Table 4: 1H-NMR Structural characterization data of synthesized GAAs 
 
CONCLUSION 
Design of smart drug carrier is currently essential for the 
progressively more demanding requirement of controlled 
drug delivery. Polymers present advantages over further 
possible constitutive materials. In this respect 
carbohydrates are getting a particular attention because of 
their identification by several endogenous carbohydrate 
proteins and their vast potential in information storage. To a 
large extent attempt is devoted to design of glycopolymers 
as key agents in drug delivery systems. This work has 
describe the conventional synthesis of glyco amino acid 
derivatives.This synthesis was based on the use of 
monosaccharide and amino acids which yields glycosylated 
amino acid building blocks that can be utilized in the 
synthesis of glycopeptides.Glyco amino acids can also be 
used to generate libraries of glycomimetics via 
derivatization and oligomerization of carbohydrates. We 
have tried to develop a method for the synthesis of 
biologically relevant glyco amino acid derivatives. This 
method provides glycoconjugates from readily available 
starting material. These derivatives possess useful 
applications in the preparation of glycoconjugates for 
subsequent immobilization, glycotargetting and as a potent 
inhibitor of carbohydrate-protein binding. 
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S. No. Compound 
Code 
NMR 
1. GAA-01 1H (CD3OD) 1.368 (2H, s, NH2), 4.967(1H,s,NH), 3.316-3.305(1H,t,HO-C-H), 3.299 (1H,s,Ar-OH). 
2. GAA-02 1H (D2O) 1.880 (2H,s,NH2), 5.296 (1H,s,NH), 0.936-0.913 (3H,d,CH3), 2.850 (1H,s,Ar-OH), 
3.731-3.709 (1H,t,HO-C-H), 1.293 (2H,m,R-CH2-R). 
3. GAA-04 1H (D2O) 2.826 (2H,s,NH2), 5.3 (1H,s,NH), 2.873 (1H,s,Ar-OH), 3.781 (1H,t,HO-C-H), 0.877-
0.799 (3H,t, CH3), 1.491 (2H,q, R-CH2-R). 
4. GAA-05 1H (D2O) 2.716 (2H,s,NH2), 5.3 (1H,s,NH), 3.672-3.637 (2H,q,CH2), 2.873 (1H,s,Ar-OH), 1.347 
(3H,d,CH3), 3.794-3.772 (1H,t,HO-C-H). 
5. GAA-06 1H (D2O) 2.074 (2H,s,NH2), 5.3 (1H,s,NH), 3.693-3.613 (2H,q,CH2), 2.855 (1H,s,Ar-OH), 0.851 
(3H,d,CH3), 3.778-3.713 (1H,t,HO-C-H). 
